ALBERTA, 1997 - Google Patents
THE LONG-TERM EFFECTIVENESS OF ANTIMALARIALS IN RHEUMATE DISEASESALBERTA, 1997
View PDF- Document ID
- 5138735851369173354
- Author
- ALBERTA E
- Publication year
External Links
Snippet
The purpose of this study was to compare the long-term effectiveness between chloroquine (CQ) and hydroxychloroquine (HCQ). Medical charts of all patients seen by 9 rheumatologists and initiating antimalarial therapy between January 1985 and December …
- 239000003430 antimalarial agent 0 title description 255
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Detecting, measuring or recording for diagnostic purposes; Identification of persons
- A61B5/48—Other medical applications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Bassez et al. | Improved mobility with metformin in patients with myotonic dystrophy type 1: a randomized controlled trial | |
| Takeuchi et al. | The prevalence of frailty and its associated factors in Japanese hemodialysis patients | |
| Knudtson et al. | Age-related eye disease, visual impairment, and survival: the Beaver Dam Eye Study | |
| Lai et al. | Effect of recombinant human insulin-like growth factor-I on progression of ALS: a placebo-controlled study | |
| Bible et al. | Efficacy of pazopanib in progressive, radioiodine-refractory, metastatic differentiated thyroid cancers: results of a phase 2 consortium study | |
| O'Gorman et al. | Literature review: preoperative radiotherapy and rectal cancer–impact on acute symptom presentation and quality of life | |
| Mantegazza et al. | The European LEMS Registry: baseline demographics and treatment approaches | |
| HUE029444T2 (en) | A composition containing an analgesic and an antihistamine | |
| Driver et al. | Prospective case–control study of nonfatal cancer preceding the diagnosis of Parkinson’s disease | |
| Sahu et al. | Shock index as a marker for mortality rates in those admitted to the medical intensive care unit from the emergency department | |
| Schwartz et al. | Tolerability and efficacy of armodafinil in naïve patients with excessive sleepiness associated with obstructive sleep apnea, shift work disorder, or narcolepsy: a 12-month, open-label, flexible-dose study with an extension period | |
| WO2021245459A1 (en) | Biomarker identification for imminent and/or impending heart failure | |
| Au et al. | Course of dermal ulcers and musculoskeletal involvement in systemic sclerosis patients in the scleroderma lung study | |
| Krumholz et al. | Health after coronary stenting or balloon angioplasty: results from the Stent Restenosis Study | |
| TURNER et al. | The evaluation of isoxsuprine hydrochloride for the treatment of navicular disease: a double blind study | |
| Ishii et al. | Characteristics of patients with hereditary transthyretin amyloidosis and an evaluation of the safety of tafamidis meglumine in Japan: an interim analysis of an all-case postmarketing surveillance | |
| ALBERTA | THE LONG-TERM EFFECTIVENESS OF ANTIMALARIALS IN RHEUMATE DISEASES | |
| Thune | A comparative study of azapropazone and indomethacin in the treatment of rheumatoid arthritis | |
| Aviña-Zubieta | The long-term effectiveness of antimalarials in rheumatic diseases. | |
| Tehrani et al. | The efficacy and safety of rapamycin in children with tuberous sclerosis: A cross-sectional study | |
| Polland et al. | STOMp: sexual function trial of overactive bladder medication | |
| Friedman et al. | Barbiturates and lung cancer: a re-evaluation. | |
| Ishimura et al. | Examination of How Pharmacists are Involved in Improving Medication Adherence for Patients with Ulcerative Colitis | |
| Masucci et al. | 4CPS-155 A new multidisciplinary model with the clinical pharmacist for medication reconciliation in the patient with advanced renal disease | |
| Prkacin et al. | [PP. 25.20] THE CHARACTERISTICS OF EARLY CHANGES IN BLOOD PRESSURE AFTER RENAL DENERVATION |